Actively Recruiting
Optical Genome Mapping in Hematological Malignancies
Led by University Hospital, Brest · Updated on 2021-08-17
200
Participants Needed
4
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer
CONDITIONS
Official Title
Optical Genome Mapping in Hematological Malignancies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Minor or adult patients
- Patients suspected of having blood cancers or already diagnosed with a blood cancer
- Patients for whom a sample is received for diagnosis in the chromosomal genetics laboratory
- No objection made or consent given
You will not qualify if you...
- Patients under judicial protection (guardianship, curatorship, etc.)
- Patients who refuse to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
CHRU de Brest
Brest, France, 29609
Actively Recruiting
2
CH Morlaix, service d'hémato clinique
Morlaix, France
Actively Recruiting
3
CHIC, service d'hémato clinique
Quimper, France
Actively Recruiting
4
CH St Brieuc, service d'hémato clinique
Saint-Brieuc, France
Actively Recruiting
Research Team
M
Marie-Bérengère, TROADEC, PhD
CONTACT
N
Nathalie DOUET-GUILBERT, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here